CClinicalTrials.gg
CompletedNCT01413217Updated Sep 15, 2022

Which is a Better Breakfast? Egg or Cereal?

An observational study in Hunger and Satiety, sponsored by Pennington Biomedical Research Center. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-09-15.

Sponsored by Pennington Biomedical Research Center · Observational

Study type
Observational
Model
Case-crossover
Time perspective
Retrospective
Enrollment
20
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Which is a better breakfast? Egg or cereal?

Read the detailed description

Which breakfast has the most beneficial effect on blood glucose and insulin, blood hormones and blood pressure, egg or cereal breakfast? Over a seven week period the participant will take part in eating breakfast of either egg breakfast or cereal breakfast which will be monitored. Blood samples will be taken before participants eat and different times throughout until after Lunch on day 1 and day 7. Questionnaires will be given to determine satiety (feeling of fullness) and hunger before and after breakfast and lunch. After a two week period participants will return for another week of the same procedure and tests that was followed from Day 1 though day 7 listed. However, this time participants will be eating the second of the two breakfasts whichever one they did not have for the first test period.

02

Conditions studied

  • Hunger
  • Satiety
03

In context

Lead sponsor

Pennington Biomedical Research Center is the lead sponsor of 277 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

In the community area of Baton Rouge, LA area exclusively random process to guarantee that each participant or population has specified chance of selection.

Eligibility criteria

Inclusion Criteria:

  • 18-60 years of age
  • not lost more than 5% of body wight in the past 3 months, or not trying to actively lose weight at the moment.
  • are not suffering from disease such as major heart conditions, cancer, type 1 diabetes, eating disorders, very high cholesterol or triglycerides levels, or any serious illness that requires intensive and long term medical treatment.

are not allergic to or sensitive to eggs, soy or wheat, and do not dislike these foods.

  • have a BMI of equal to or >30 to equal to or \<60
05

Study design

Observational model
Case-crossover
Time perspective
Retrospective
Enrollment
20 participants (actual)

Groups and cohorts

  • Egg Breakfast

    This group will be given a breakfast consisting of eggs. A breakfast consisting of eggs induces greater satiety and reduces Lunch Time intake.

  • Cereal Breakfast

    This breakfast will consist of a breakfast that will include cereal. A breakfast cereal or white bread increases lunchtime energy intake.

06

What researchers measure

Primary outcomes

  1. Caloric intake for Lunch after you have received an Egg or Cereal Breakfast and Levels of glucose, insulin, and lipids are measured.

    Before breakfast satiety following an egg breakfast compared to the other breakfast determines the impact of egg breakfast on their Lunch intake. Blood samples will be taken to test the levels of glucose, insulin, and lipids like cholesterol and triglycerides.

    Time frame: 7 weeks

Secondary outcomes

  1. Satiety or hunger

    Questionnaires to determine satiety and/or hunger before and after breakfast and lunch will be given.

    Time frame: 7 weeks

07

Study locations

1 site
  • Pennington Biomedical Research Center
    Baton Rouge, Louisiana 70808, United States
08

References and documents

Publications

  • Bayham BE, Greenway FL, Johnson WD, Dhurandhar NV. A randomized trial to manipulate the quality instead of quantity of dietary proteins to influence the markers of satiety. J Diabetes Complications. 2014 Jul-Aug;28(4):547-52. doi: 10.1016/j.jdiacomp.2014.02.002. Epub 2014 Feb 13. PubMed 24703415 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 15, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01413217
Lead sponsor
Pennington Biomedical Research Center
Collaborators
American Egg Board
Responsible party
Sponsor
First posted
Aug 10, 2011
Start date
Jul 2010
Primary completion
Sep 2011
Completion
Sep 2011
Last update
Sep 15, 2022

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion